Skip to main content
. 2025 Jul 18;15(7):1137. doi: 10.3390/life15071137
6MWD Six-minute walking distance
BPA Balloon pulmonary angioplasty
BMPR2 Bone morphogenetic protein receptor type 2
BNP Brain natriuretic peptide
CCBs Calcium channel blockers
CPET Cardiopulmonary Exercise Testing
ppm Cases per million
CLD Chronic lung disease
COPD Chronic obstructive pulmonary disease
CTEPH Chronic thromboembolic pulmonary hypertension
CPFE Combined pulmonary fibrosis and emphysema
CHD Congenital heart disease
CPAP Continuous positive airway pressure
DECT Dual-energy computed tomography
ERAs Endothelin receptor antagonists
ESC European Society of Cardiology
HF Heart failure
HFmrEF Heart failure with mildly reduced ejection fraction
HFpEF Heart failure with preserved ejection fraction
HFrEF Heart failure with reduced ejection fraction
HPAH Heritable PAH
IPAH Idiopathic PAH
IPF Idiopathic pulmonary fibrosis
IL-6 Interleukin-6
ILD Interstitial lung disease
LHD Left heart disease
mPAP Mean pulmonary arterial pressure
NO Nitric oxide
PDE5i Phosphodiesterase type 5 inhibitor
PDGF Platelet-derived growth factor
PAs Prostacyclin analogs
PRAs Prostacyclin receptor agonists
PAH Pulmonary arterial hypertension
PAWP Pulmonary artery wedge pressure
PEA Pulmonary endarterectomy
PH Pulmonary hypertension
PPHN Pulmonary hypertension of the newborn
PVR Pulmonary vascular resistance
PVOD Pulmonary veno-occlusive disease
RHC Right heart catheterization
sGCS Soluble guanylate cyclase stimulator
TGF-β Transforming growth factor-beta
V/Q Ventilation/perfusion
WU Wood Units
WHO World Health Organization
WSPH World Symposium on Pulmonary Hypertension